Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
zidesamtinib (NVL-520)
i
Other names:
NVL-520, NUV-520
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Nuvalent
Drug class:
ROS1 inhibitor
Related drugs:
‹
entrectinib (178)
lorlatinib (94)
repotrectinib (27)
iruplinalkib (11)
SAF-189 (7)
unecritinib (6)
taletrectinib (5)
SIM1803-1A (5)
APG-2449 (4)
envonalkib (3)
TGRX-326 (3)
AGX87 (0)
TY-2136b (0)
XZP-5955 (0)
dirozalkib (0)
ZG0418 (0)
entrectinib (178)
lorlatinib (94)
repotrectinib (27)
iruplinalkib (11)
SAF-189 (7)
unecritinib (6)
taletrectinib (5)
SIM1803-1A (5)
APG-2449 (4)
envonalkib (3)
TGRX-326 (3)
AGX87 (0)
TY-2136b (0)
XZP-5955 (0)
dirozalkib (0)
ZG0418 (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.